Questions persist about sexual effects of baldness drug
http://news.yahoo.com/questions-persist-...01862.html
"People who take or prescribe the drug assume it's safe, but there is insufficient information to make that judgment," said lead study author Steven Belknap, research assistant professor of dermatology and general internal medicine at Northwestern University Feinberg School of Medicine.
"Our findings raise several questions," Belknap said.
"Why do the published reports of these 34 clinical trials not provide adequate information about the severity and frequency of sexual toxicity? Was this information obtained but then not included in published articles? Or, were these clinical trials performed in a way that simply didn't capture this essential information? And most importantly, is the risk to benefit ratio of finasteride acceptable?"
http://news.yahoo.com/questions-persist-...01862.html
"People who take or prescribe the drug assume it's safe, but there is insufficient information to make that judgment," said lead study author Steven Belknap, research assistant professor of dermatology and general internal medicine at Northwestern University Feinberg School of Medicine.
"Our findings raise several questions," Belknap said.
"Why do the published reports of these 34 clinical trials not provide adequate information about the severity and frequency of sexual toxicity? Was this information obtained but then not included in published articles? Or, were these clinical trials performed in a way that simply didn't capture this essential information? And most importantly, is the risk to benefit ratio of finasteride acceptable?"